Almonty, Paid-for

Almonty: A Paid-for $20 Target, a Stifel Cut, and the October Cargo That Has to Sail

Published on 10/21/2026 at 22:01 | Editorial boerse-global.de
Oppenheimer reiterates Outperform while Stifel trims its target on delivery delays; a paid Diamond Equity report ties its $20 illustrative value to execution.
Almonty Industries Inc Wolframerz CA0203987072 als Flatlay mit Geologen-Hammer, Lupe und Geländekarte Illustration mit AI erstellt.

Two research notes landed on Almonty this week, and they pull in opposite directions. Oppenheimer reaffirmed its "Outperform" rating, while Stifel trimmed its price target on delivery delays. Yet the more telling document may be a third one: an updated report from Diamond Equity Research, for which Almonty has paid US$100,000 to date. That funding arrangement doesn't make the conclusions wrong — but it belongs right next to the valuation, not tucked into a footnote.

The report floats an illustrative value of US$20.00 per share, and the qualifier matters as much as the number. That figure is explicitly tied to execution. It is not an unconditional verdict on what the stock must be worth, and that caveat deserves at least as much investor attention as the headline figure itself.

What the paid report actually credits

On operations, Diamond Equity points to Sangdong's completed certification and the first tungsten concentrate production since 1993, with the second expansion phase now under way. Those are tangible milestones. They answer a different question than the one about a durable valuation, though — and the report's own execution clause sits precisely in that gap.

The next date on the calendar is a first booked shipment on October 24, 2026. "Booked" is the operative word: a scheduled cargo is not a completed delivery. Between those two states lies the entire execution risk the report itself flags.

Should investors sell immediately? Or is it worth buying Almonty?

None of this necessarily contradicts the production story. A plant can ramp up while expectations for the delivery timeline shift. What matters for sizing up the equity is not only whether Almonty is making headway, but which steps are already finished and which are still pending.

The stock gained 4.7% today. That move cannot be reliably attributed to the new research note, so the advance is no proof that the market is endorsing its valuation.

Sangdong's sequence, step by step

Almonty restarted operations at its Sangdong tungsten mine in South Korea and received the final operating permit on September 22. A week later, the company reported the first bags of tungsten concentrate — the first tungsten produced there in 33 years. That sequence is substantial and distinguishes the story from a mere project announcement.

Still, investors shouldn't conflate the individual steps. A permit allows operation; produced concentrate proves the ramp-up; a commercial delivery would be the next piece of evidence. Each step counts, but each answers a different question.

Phase II remains part of the longer view, slated for completion in 2027 and designed to lift capacity to as much as 1.2 million tonnes annually. That is an opportunity with a clear condition attached: the planned expansion must not crowd out scrutiny of how the current operation is actually executed.

Almonty at a turning point? This analysis reveals what investors need to know now.

Strategic tailwinds aren't orders

Sangdong gains additional relevance from the US procurement restriction on tungsten from China, Russia, North Korea and Iran, which takes effect January 1, 2027. Almonty's production outside those countries fits a shifting sourcing landscape in principle. That argues for the project's strategic importance — but it proves neither extra orders nor specific revenue for Almonty. Jumping from a friendlier policy environment straight to commercial success would be the wrong leap.

Weighing it all up, the two analyst camps need not be treated as a referendum on the shares. A company can make operational progress and still fall behind the schedule baked into valuations. The 35% decline over the past 30 days underscores skepticism about the story so far, though it implies neither automatic undervaluation nor a rebuttal of the operating narrative — it shows how little production progress alone can do to convince the market.

Oppenheimer's confidence is understandable; Stifel's warning on delivery delays deserves equal weight. The judgment stays cautiously constructive: the opportunity has become more concrete, and it becomes more credible only when announced shipments turn into actual business.

Ad

Almonty Stock: New Analysis - 21 October

Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Almonty analysis...

Disclaimer...
en | CA0203987072 | ALMONTY | boerse | 70388518 |